AOAC OMB Meeting Book 2-10-16
|
AOAC OMB Meeting Book |
1 |
|
Table of Contents |
2 |
|
OMB Roster |
4 |
|
Item I - Preliminary Items |
5 |
|
Memo-Items I.b Call to Order... & I.c Review of Policy Documents |
5 |
|
AOAC Bylaws/Policy Documents and ToR |
7 |
|
AOAC Bylaws |
7 |
|
Policy on the Use of Association Name... |
19 |
|
Policy on AntiTrust |
23 |
|
Policy on Procedures on Volunteer Conflict of Interest |
27 |
|
OMB Terms of Reference |
29 |
|
Item I.d - OMB Draft Meeting Agenda |
33 |
|
Memo-Item I.e - Review of November 12, 2015 Minutes |
35 |
|
November 12, 2015 - Draft Meeting Minutes |
35 |
|
Memo-Item I.f - OMB Report to BoD |
39 |
|
Memo-Item I.g - December 2015 BoD Meeting |
41 |
|
Memo-Item I.h - AOAC Final Action...Road to Codex |
42 |
|
Item II - Official Methods of Analysis |
51 |
|
Memo-Item II.a - Revise Method Format |
51 |
|
Memo-Item II.b - Revise Appendix F |
58 |
|
Memo-Item II.c - New in 20th Edition of OMA |
95 |
|
Memo-Item II.d - Sole Source Modification |
96 |
|
Working Group Summary-Sole Source Modification |
97 |
|
Revised Flow Sole Source Modification |
102-103 |
|
Item III - Expert Review Panels (ERP) |
105 |
|
Memo-Item III.a - First to Final Action |
105 |
|
i. First to Final Action Working Group Summary |
106 |
|
iii. Recommendation to Revise Appendix G |
108 |
|
iv. OMB First to Final Presentation |
114-115 |
|
Path to Final Action |
114-115 |
|
Standard Method Performance Pathway |
116-117 |
|
OMB Liaison |
118-119 |
|
Method Applicability |
120-121 |
|
Safety Concerns |
122-123 |
|
Reference Materials |
124-125 |
|
Single Laboratory Validation |
126-127 |
|
Quantitative Reproducibility/Uncertainty |
128-129 |
|
Qualitative Reproducibility/Uncertainty |
130-131 |
|
Compare to SMPR |
132-133 |
|
Feedback from Users |
134-135 |
|
Feedback from Users |
136-137 |
|
ERP Recommendations |
138-139 |
|
AOAC INTERNATIONAL |
140-141 |
|
Memo-Item III.b - ERP Recommendations for Final Action |
143 |
|
i. ERP for Microbiology Methods |
143 |
|
ii. ERP for Veterinary Drug Residues |
151 |
|
Memo-Item III.c - Process Overview |
153 |
|
Memo-Item III.d - Modifications to ERPs |
154 |
|
i. Dietary Supplements - Ashwagandha, Folic C & Kratom |
154 |
|
ii. SPSFAM - Heavy Metals |
156 |
|
iii. SPIFAN II Nutrients |
157 |
|
Book Cover |
157 |
|
SPIFAN ERP to OMB_TOC_2-2016 |
159 |
|
SPIFAN ERP - Memo_Feb 2016 |
160 |
|
ERP Roster - 2-5-16 |
161 |
|
SPIFAN ERP to OMB_Perspective_2-2016 |
162 |
|
Woollard, David CV |
163 |
|
Woollard, David CV-2014 |
164 |
|
Item IV - Stakeholder Panels |
171 |
|
Memo-Item IV.a - AOAC Mid-Year /OMB Liaison |
171 |
|
Memo-Item IV.b - Vetting SP Co-Chair |
172 |
|
Item V - AOAC Official Methods Board Maintenance |
173 |
|
Memo-Item V.a - Documentation |
173 |
|
Item Va.i.-OMB Terms of Reference |
174 |
|
Item Va.ii.-OMB New Member Selection |
176 |
|
Item Va.iii.-OMB Vice Chair Selection |
177 |
|
Committee on Safety ToR |
178 |
|
Committee on Statistics ToR |
180 |
|
Memo-Item V.b - Awards Update |
184 |
|
Official Methods Program Awards |
185 |
|
Memo-Item V.c - OMB New Member Selection WG |
190 |
|
Memo-Item V.d - OMB Next Teleconference |
191 |